COURTNEY ISSIS-BANUELOS: Open Payments
NPI 1295413391 · BESSEMER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 47 payments from 13 companies in 2025. Trend: 2023 $38 · 2024 $552 · 2025 $910
Food & beverage: $910
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $157 |
| Dexcom, Inc. | 7 | $155 |
| Amgen Inc. | 7 | $134 |
| Insmed, Inc. | 3 | $89 |
| PFIZER INC. | 4 | $73 |
| Lilly USA, LLC | 4 | $66 |
| Viatris Specialty LLC | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Corcept Therapeutics | 1 | $26 |
Products named: Dexcom G6 Transmitter, KRYSTEXXA, Arikayce, Ozempic, Wegovy, YUPELRI, MOUNJARO, ELIQUIS.
Industry payments across AL — which companies pay providers there.
